Sublingual tissue perfusion improves during emergency treatment of acute decompensated heart failure

被引:10
|
作者
Hogan, Christopher J. [1 ,2 ,3 ]
Ward, Kevin R. [2 ,3 ]
Franzen, Douglas S. [2 ,3 ]
Rajendran, Bipin [2 ]
Thacker, Leroy R. [4 ,5 ]
机构
[1] Virginia Commonwealth Univ, Med Ctr, Dept Emergency Med, Dept Surg,Div Crit Care Trauma, Richmond, VA 23238 USA
[2] Virginia Commonwealth Univ, Med Ctr, Dept Emergency Med, Richmond, VA 23298 USA
[3] Virginia Commonwealth Univ, Med Ctr, Virginia Commonwealth Univ Reanimat Engn Sci Ctr, Richmond, VA 23298 USA
[4] Virginia Commonwealth Univ, Dept Biostat, Richmond, VA 23298 USA
[5] Virginia Commonwealth Univ, Ctr Clin & Translat Res, Richmond, VA 23298 USA
来源
关键词
MICROCIRCULATORY PERFUSION; THERAPY; DYSPNEA; RESUSCITATION; NITROGLYCERIN; MANAGEMENT; DIAGNOSIS; PROTOCOL; CRITERIA; OUTCOMES;
D O I
10.1016/j.ajem.2011.06.005
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objectives: The aim of this study was to measure sublingual perfused capillary density (PCD) to assess sublingual microvascular perfusion during emergency department (ED) treatment of acute decompensated heart failure (ADHF). Methods: This prospective, observational study enrolled ED patients with ADHF, measuring pre- and post-ED treatment PCD. Sidestream dark-field imaging was analyzed by 3 investigators blinded to patient identifiers and time points. Patient demographics, ADHF etiology, serum brain natriuretic peptide, and hemoglobin were measured along with a visual analogue scale (VAS), which assessed patient baseline characteristics and response to ED treatment. A paired t test analyzed changes in PCD, mean arterial pressure (MAP), and patient assessment. Interrater variability was assessed with an intraclass correlation coefficient (ICC), with a P value <.05 considered significant for all testing. Results: Thirty-six patients were enrolled with a mean time between pretreatment and posttreatment PCD (+/- SD) of 138 +/- 59 minutes and a hospital length of stay of 4.0 +/- 4.1 days. During this time, PCD increased (difference, 1.3 mm/mm(2); 95% confidence interval, 0.4-2.1; P = .004), as did the MAP (P = .002), patient VAS score (P < .001), and observer VAS score (P < .001). There was no correlation between the change in PCD and time (R-2 =.016, P = .47), MAP (R-2 = .013, P = .54), or VAS scores. The ICC was 0.954. Conclusions: Sublingual tissue perfusion is diminished in ADHF but increases with treatment. It may represent a quantitative way to evaluate ADHF in the ED setting. (C) 2011 Published by Elsevier Inc.
引用
下载
收藏
页码:872 / 880
页数:9
相关论文
共 50 条
  • [31] Acute Decompensated Heart Failure
    Brown, Jennifer R.
    Gottlieb, Stephen S.
    CARDIOLOGY CLINICS, 2012, 30 (04) : 665 - +
  • [32] Acute decompensated heart failure
    Smithline, Howard A.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2007, 177 (02) : 175 - 175
  • [33] THE PREDICTIVE VALUE OF HEMOCONCENTRATION AND HEMOGLOBIN LEVEL DURING THE TREATMENT OF ACUTE DECOMPENSATED HEART FAILURE
    Kono, Hiroyuki
    Kitai, Takeshi
    Kim, Kitae
    Ehara, Natsuhiko
    Kobori, Atsushi
    Kinoshita, Makoto
    Kaji, Shuichiro
    Furukawa, Yutaka
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 1001 - 1001
  • [34] Predictive Value of Spot Urine Sodium during the Treatment of Acute Decompensated Heart Failure
    Kono, Hiroyuki
    Kitai, Takeshi
    Tang, W. H. Wilson
    Sasaki, Yasuhiro
    Toyota, Toshiaki
    Kim, Kitae
    Ehara, Natsuhiko
    Kobori, Atsushi
    Kinoshita, Makoto
    Kaji, Shuichiro
    Furukawa, Yutaka
    JOURNAL OF CARDIAC FAILURE, 2019, 25 (08) : S15 - S15
  • [35] RED BLOOD CELL DISTRIBUTION WIDTH IMPROVES RECLASSIFICATION OF PATIENTS ADMITTED TO THE EMERGENCY DEPARTMENT WITH ACUTE DECOMPENSATED HEART FAILURE
    Turcato, Gianni
    Cervellin, Gianfranco
    Bonora, Antonio
    Prati, Danieli
    Zorzi, Elisabetta
    Ricci, Giorgio
    Salvagno, Gian Luca
    Maccagnani, Antonio
    Lippi, Giuseppe
    JOURNAL OF MEDICAL BIOCHEMISTRY, 2018, 37 (03) : 299 - 306
  • [36] Electrolyte Variability During Acute Decompensated Heart Failure Hospitalization
    Gulati, Jaskeerat S.
    Kimbrell, Michael
    Zhong, Lin
    Wang, Yiqing
    Yang, Donghan
    Roehm, Bethany
    Hedayati, Susan S.
    Farr, Mary Jane
    Hendren, Nicholas
    Drazner, Mark
    Tang, Wai Hong
    Grodin, Justin
    JOURNAL OF CARDIAC FAILURE, 2024, 30 (01) : 242 - 243
  • [37] Resource use during hospitalization for acute decompensated heart failure
    Seybert, AL
    Kane-Gill, SL
    Spates, J
    Shatzer, M
    Saul, MI
    Kirisci, L
    Murali, S
    CIRCULATION, 2005, 111 (20) : E341 - E342
  • [38] Looking for Medications to Support the Treatment of Acute Decompensated Heart Failure
    Zymlinski, Robert
    Stepinska, Janina
    CARDIOLOGY, 2020, 145 (04) : 224 - 226
  • [39] Study of the Benefit of Empagliflozin in the Treatment of Acute Decompensated Heart Failure
    Liu, Ya
    Hu, Jing
    Xu, Guang
    Feng, Xiuyuan
    Li, Chujuan
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 85 : 243 - 249
  • [40] Acute decompensated heart failure: Rethinking the economics and treatment - Introduction
    Munger, MA
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2003, 60 (16) : S2 - S2